
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7487912
[patent_doc_number] => 20110251250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'USE OF DIMIRACETAM IN THE TREATMENT OF CHRONIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 13/166088
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5405
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251250.pdf
[firstpage_image] =>[orig_patent_app_number] => 13166088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/166088 | Use of dimiracetam in the treatment of chronic pain | Jun 21, 2011 | Issued |
Array
(
[id] => 7662259
[patent_doc_number] => 20110311528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'USE OF 2,5-DIHYDROXYBENZENE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT OF PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 13/166569
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15243
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311528.pdf
[firstpage_image] =>[orig_patent_app_number] => 13166569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/166569 | Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis | Jun 21, 2011 | Issued |
Array
(
[id] => 7733607
[patent_doc_number] => 20120015964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA'
[patent_app_type] => utility
[patent_app_number] => 13/163597
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41624
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015964.pdf
[firstpage_image] =>[orig_patent_app_number] => 13163597
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/163597 | QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | Jun 16, 2011 | Abandoned |
Array
(
[id] => 9286239
[patent_doc_number] => 08642568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Method of diagnosing and therapeutically treating a patient for a traumatic brain injury'
[patent_app_type] => utility
[patent_app_number] => 13/160735
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 2863
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13160735
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/160735 | Method of diagnosing and therapeutically treating a patient for a traumatic brain injury | Jun 14, 2011 | Issued |
Array
(
[id] => 8884914
[patent_doc_number] => 20130158098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'Alkenyl Substituted Cycloaliphatic Compounds as Chemical Inducers of Proximity'
[patent_app_type] => utility
[patent_app_number] => 13/704517
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 25434
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704517
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/704517 | Alkenyl Substituted Cycloaliphatic Compounds as Chemical Inducers of Proximity | Jun 14, 2011 | Abandoned |
Array
(
[id] => 8516755
[patent_doc_number] => 20120316164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/158783
[patent_app_country] => US
[patent_app_date] => 2011-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4144
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13158783
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/158783 | METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELLS | Jun 12, 2011 | Abandoned |
Array
(
[id] => 7490322
[patent_doc_number] => 20110237572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/157893
[patent_app_country] => US
[patent_app_date] => 2011-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42944
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237572.pdf
[firstpage_image] =>[orig_patent_app_number] => 13157893
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/157893 | Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives | Jun 9, 2011 | Abandoned |
Array
(
[id] => 7490757
[patent_doc_number] => 20110237672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production'
[patent_app_type] => utility
[patent_app_number] => 13/155627
[patent_app_country] => US
[patent_app_date] => 2011-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2342
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237672.pdf
[firstpage_image] =>[orig_patent_app_number] => 13155627
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/155627 | Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production | Jun 7, 2011 | Abandoned |
Array
(
[id] => 8932668
[patent_doc_number] => 08492367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea'
[patent_app_type] => utility
[patent_app_number] => 13/154164
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15178
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154164
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/154164 | Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea | Jun 5, 2011 | Issued |
Array
(
[id] => 8721357
[patent_doc_number] => 20130072574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO PROMOTE ENHANCED SIRTUIN, CELL AND TELOMERE INTEGRITY'
[patent_app_type] => utility
[patent_app_number] => 13/699779
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12568
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699779
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699779 | Dietary supplements containing extracts of cinnamon and methods of using same to promote enhanced sirtuin, cell and telomere integrity | May 25, 2011 | Issued |
Array
(
[id] => 7568044
[patent_doc_number] => 20110288107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'TOPICAL FORMULATION FOR A JAK INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/112370
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16460
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288107.pdf
[firstpage_image] =>[orig_patent_app_number] => 13112370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112370 | TOPICAL FORMULATION FOR A JAK INHIBITOR | May 19, 2011 | Abandoned |
Array
(
[id] => 7487714
[patent_doc_number] => 20110236506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'PHARMACEUTICAL ASSOCIATION CONTAINING LIPOIC ACID AND HYDROXYCITRIC ACID AS ACTIVE INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/099897
[patent_app_country] => US
[patent_app_date] => 2011-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10763
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236506.pdf
[firstpage_image] =>[orig_patent_app_number] => 13099897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/099897 | PHARMACEUTICAL ASSOCIATION CONTAINING LIPOIC ACID AND HYDROXYCITRIC ACID AS ACTIVE INGREDIENTS | May 2, 2011 | Abandoned |
Array
(
[id] => 6064400
[patent_doc_number] => 20110201645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate'
[patent_app_type] => utility
[patent_app_number] => 13/093917
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2673
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201645.pdf
[firstpage_image] =>[orig_patent_app_number] => 13093917
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/093917 | Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate | Apr 25, 2011 | Abandoned |
Array
(
[id] => 10031446
[patent_doc_number] => 09072746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Method for enhancing learning and memory impaired by neurodegenerative disorders and compounds and compositions for effecting the same'
[patent_app_type] => utility
[patent_app_number] => 13/641987
[patent_app_country] => US
[patent_app_date] => 2011-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14490
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641987
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641987 | Method for enhancing learning and memory impaired by neurodegenerative disorders and compounds and compositions for effecting the same | Apr 21, 2011 | Issued |
Array
(
[id] => 7710186
[patent_doc_number] => 20120003213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'Methods Of Enhancing Antibody-Dependent Cellular Cytotoxicity'
[patent_app_type] => utility
[patent_app_number] => 13/092088
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15096
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13092088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/092088 | Methods of enhancing antibody-dependent cellular cytotoxicity | Apr 20, 2011 | Issued |
Array
(
[id] => 8768086
[patent_doc_number] => 20130096123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'RADIATION SENSITISER COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/640975
[patent_app_country] => US
[patent_app_date] => 2011-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7337
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640975 | RADIATION SENSITISER COMPOSITIONS | Apr 13, 2011 | Abandoned |
Array
(
[id] => 10103801
[patent_doc_number] => 09139575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Broad spectrum antiviral and antiparasitic agents'
[patent_app_type] => utility
[patent_app_number] => 13/640732
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22586
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640732
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640732 | Broad spectrum antiviral and antiparasitic agents | Apr 12, 2011 | Issued |
Array
(
[id] => 7818636
[patent_doc_number] => 20120065256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'MILBEMYCIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 13/079993
[patent_app_country] => US
[patent_app_date] => 2011-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3161
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065256.pdf
[firstpage_image] =>[orig_patent_app_number] => 13079993
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/079993 | MILBEMYCIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH | Apr 4, 2011 | Abandoned |
Array
(
[id] => 7720942
[patent_doc_number] => 20120010277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 13/080111
[patent_app_country] => US
[patent_app_date] => 2011-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3004
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010277.pdf
[firstpage_image] =>[orig_patent_app_number] => 13080111
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/080111 | AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH | Apr 4, 2011 | Abandoned |
Array
(
[id] => 7712140
[patent_doc_number] => 20120004295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'ADMINISTRATION OF 6\'-ETHYL LEPIMECTIN, 6\'-METHYL LEPIMECTIN OR DERIVATIVES THEREOF FOR TREATING DERMATOLOGICAL DISORDERS IN HUMANS'
[patent_app_type] => utility
[patent_app_number] => 13/080026
[patent_app_country] => US
[patent_app_date] => 2011-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2906
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13080026
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/080026 | ADMINISTRATION OF 6'-ETHYL LEPIMECTIN, 6'-METHYL LEPIMECTIN OR DERIVATIVES THEREOF FOR TREATING DERMATOLOGICAL DISORDERS IN HUMANS | Apr 4, 2011 | Abandoned |